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Lamins are major structural proteins of the nucleus and are essential for nuclear integrity and organization of nuclear
functions. Mutations in the human lamin genes lead to highly degenerative genetic diseases that affect a number of
different tissues such as muscle, adipose or neuronal tissues, or cause premature ageing syndromes. New findings on
the role of lamins in cellular signalling pathways, as well as in ubiquitin-mediated proteasomal degradation, have
given important insights into possible mechanisms of pathogenesis.
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1. Nuclear lamins
The nuclear lamina is the main architectural component of
the metazoan nucleus and encompasses a filamentous
protein network that is associated with the inner nuclear
membrane and also extends into the interior of the nucleus.
The major components of the lamina are a group of nuclear
proteins termed the lamins, which belong to the type V
intermediate filament superfamily of proteins. The lamina
plays an essential role in maintaining the integrity of the
nuclear envelope and provides anchoring sites for chroma-
tin. Lamins are involved in the organization of nuclear
functions such as DNA replication and transcription, and
have been proposed to play important roles in diverse
cellular pathways. Two major kinds of lamins are present in
higher eukaryotes. The B-type lamins are constitutively
expressed in all somatic cell types, whereas the expression
of A-type lamins is restricted to differentiated cells of most
lineages. More than 250 mutations in the human lamin A
gene (LMNA) have been associated with at least 15
debilitating inherited diseases, collectively termed lamino-
pathies, that affect specific tissues such as skeletal muscle,
cardiac muscle, adipose tissue and bone, and also cause
premature ageing or progeria syndromes. Mutations in
lamin B1 and lamin B2 genes as well as genes coding for
various nuclear membrane proteins have also been associ-
ated with heritable diseases. Current research in this area has
given valuable insights into possible mechanisms of
pathogenesis and additional functional roles of lamins,
especially in specific signalling pathways. This review
summarizes recent findings on the deleterious effects of
lamin mutations on nuclear organization and function, and
explores the possibility that nuclear dysfunction is due to
proteasomal degradation of essential proteins. More detailed
information on various aspects of lamin biology has been
covered in excellent reviews on the subject (Worman and
Courvalin 2005; Broers et al. 2006; Capell and Collins
2006; Dechat et al. 2008; Parnaik 2008).
The A- and B-type lamins differ in their solubility
properties, expression patterns and localization during
mitosis (Goldman et al. 2002; Herrmann et al. 2007).
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Lamins A and C (henceforth called lamin A/C) are
alternatively spliced products of the lamin A gene, LMNA,
whereas lamins B1 and B2 are coded by two separate genes,
LMNB1 and LMNB2. Additional splice variants of the
lamins are germ-cell-specific lamins C2 and B3, which are
encoded by LMNA and LMNB2, respectively, and a minor
somatic cell isoform of lamin A termed lamin AΔ10. LMNA
has been mapped to the locus 1q21.2-q21.3 in the human
genome, whereas LMNB1 and LMNB2 have been mapped to
the loci 5q23.3-q31.1 and 19p13.3, respectively. Drosophila
melanogaster has two lamin genes, the B-type lamin Dm0
gene (lamDm0), which is expressed in most cells and the A-
type lamin C gene (lamC), whose expression is develop-
mentally regulated. Caenorhabditis elegans has only one
lamin gene, lmn-1, which is expressed in all cells except the
mature sperm. Genome sequence analysis of yeast and
Arabidopsis indicates that these species do not have lamins.
Thus, lamins appear to have evolved in animal cells.
Lamins are characterized by a tripartite structure consist-
ing of a central α-helical rod domain flanked by non-helical
N-terminal ‘head’ and C-terminal ‘tail’ domains that is
typical of intermediate filament proteins (Herrmann et al.
2007). The central rod domain drives the interaction
between two lamin proteins to form a coiled-coil dimer,
the basic structural unit of lamin assembly. The head-to-tail
associations between two lamin dimers lead to the formation
of protofilaments that have the propensity to associate
laterally in different configurations such as parallel, stag-
gered or half-staggered to give rise to the 10 nm lamin
filament. The three-dimensional crystal structure of the
lamin A/C globular tail domain has revealed a compact,
well-defined structure termed the immunoglobulin (Ig)
domain or fold; Ig domains serve as structural scaffolds or
may mediate specific intermolecular interactions with other
proteins. Most of the disease-causing mutations in the rod
domain affect lamin assembly and cause increased mobility
of lamins in live cells (Gilchrist et al. 2004; Broers et al.
2005; Tripathi et al. 2009).
The C-terminii of lamins A, B1 and B2 bear a CaaX
motif (C, cysteine; a, aliphatic; X, any amino acid), which is
post-translationally modified by cysteine farnesylation fol-
lowed by proteolytic cleavage of the last three amino acids
(aaX) and methyl esterification of the carboxyl group of the
farnesylated cysteine residue. Farnesylation appears to be
required for increasing the hydrophobicity of the C-terminus
to allow targeting of lamins to the inner surface of the
nuclear envelope. After nuclear envelope localization, the
18 C-terminal residues of pre-lamin A, including the
farnesylated cysteine, are cleaved off by the ZMPSTE24
protease to form mature lamin A.
In addition to their typical localization at the nuclear
periphery, lamins have also been detected in the interior of
the nucleus in the form of foci or a diffuse network. Some of
these intranuclear lamin structures have been implicated in
establishing patterns of DNA replication sites (Moir et al.
1994; Kennedy et al. 2000) and in organizing transcription
(Jagatheesan et al. 1999; Kumaran et al. 2002). Lamins are
dispersed at the onset of mitosis, as a consequence of
phosphorylation of essential serine residues on either end of
the rod domain of lamin by cyclin-dependent kinase 1
(Cdk1), which results in depolymerization of the lamina into
dimers and tetramers. The lamina is reassembled towards
late telophase and in early G1 phase of the cell cycle (Gant
and Wilson 1997).
Lamins can bind to two broad categories of proteins,
nuclear membrane proteins and gene regulatory proteins
(Worman and Courvalin 2005; Wilson and Foisner 2010).
Several inner nuclear membrane proteins interact directly
with lamins, which helps to anchor lamin filaments to the
nuclear envelope. Prominent lamin-binding proteins are
emerin, lamin B receptor and lamin-associated-
polypeptides (LAPs) 1 and 2. Emerin, LAP2 and another
envelope protein MAN1 possess a 40-residue folded motif
called the LEM domain (derived from LAP, emerin,
MAN1) that binds directly to barrier-to-autointegration
factor (BAF), a conserved DNA-binding protein that is
involved in higher-order chromatin structure and in nuclear
assembly. Emerin has been reported to stabilize β-catenin
and thereby influence the onset of adipogenesis (Tilgner et
al. 2009). LAP2α forms functional complexes with lamin A
and retinoblastoma protein (pRb) in the interior of the
nucleus (Dechat et al. 2000; Markiewicz et al. 2002).
The nuclear envelope comprises approximately 80
transmembrane proteins (Schirmer and Gerace 2005). Two
important families of nuclear membrane-bound proteins are
the nesprins and the SUNs (Starr 2009). The nesprins (also
called Syne/ANC-1 proteins) are large, actin-binding pro-
teins that span the outer nuclear membrane, and exist in
many forms with tissue-specific expression patterns due to
alternate splicing. Most SUN (Sad1/UNC-84 homology)
domain proteins contain multiple transmembrane domains
and localize to the inner nuclear membrane. The N-terminal
domains of SUN-1 and SUN-2 are located in the nucleo-
plasm and bind directly to A-type lamins; the C-terminal
domains are localized in the lumen of the nuclear envelope,
where they interact with nesprins. The nesprins and SUN
domain proteins have been proposed to bridge the nuclear
envelope and provide connectivity between the nucleus and
cytoskeleton during processes such as nuclear positioning
and migration.
There is substantial evidence that lamin A/C associates
with specific gene regulatory factors as well as signalling
molecules and thereby modulates their activities (Wilson
and Foisner 2010). A few examples are described here. The
active hypophosphorylated form of pRb, a tumour suppres-
sor protein involved in regulation of the cell cycle and
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apoptosis as well as in muscle and adipocyte differentiation,
can bind to A-type lamins and also interact with LAP2α,
and LAP2α–lamin A/C complexes are able to anchor pRb to
the nuclear envelope (Markiewicz et al. 2002). Cyclin D3
interacts directly with lamin A/C in muscle cells, and
binding interactions between lamin A/C, pRb and cyclin D3
are likely to play an important role in muscle differentiation
(Mariappan and Parnaik 2005; Mariappan et al. 2007).
Lamin A has been reported to bind to c-Fos and sequester it
at the nuclear periphery, leading to repression of AP-1
transcriptional activity (Ivorra et al. 2006). An adipocyte
differentiation factor, sterol response element binding
protein 1 (SREBP1) has been shown to interact directly
with lamin A by binding to the Ig-fold of the lamin A/C tail
domain (Lloyd et al. 2002). The Ig-fold domain also binds
directly to the DNA replication factor, proliferating cell
nuclear antigen (PCNA), and this association has been
proposed to be important for the spatial organization of
DNA replication (Shumaker et al. 2008). Heat shock
proteins like Hsp70 as well as small heat shock proteins
associate with nuclear lamins and might be required to
stabilise intranuclear lamin A/C under heat stress conditions
(Willsie and Clegg 2002; Adhikari et al. 2004).
2. Laminopathies
Mutations in LMNA are associated with tissue-specific
laminopathies that affect striated muscles, adipose tissue
and peripheral nerves, and also cause premature ageing
syndromes that afflict several tissues (figure 1). Certain
cases of overlapping symptoms have also been described.
The clinical condition termed Emery-Dreifuss muscular
dystrophy (EMD) can be caused by mutations in the gene
coding for emerin or lamin A/C (Bione et al. 1994; Bonne
et al. 1999), and has also been linked to mutations in genes
coding for other nuclear membrane proteins. The disease is
marked by contractures of the elbows, Achilles tendons and
posterior neck, slow progressive muscle wasting and dilated
cardiomyopathy with atrioventricular conduction block. The
majority of EMD mutations in LMNA are missense
mutations and a few are small deletions or nonsense
mutations; mutations are found in all exons of the gene.
Most mutations are autosomal dominant, and both familial
and sporadic mutations have been identified. Autosomal
dominant mutations in LMNA are the most common cause
of dilated cardiomyopathy (DCM) (Fatkin et al. 1999) and
lead to a particularly severe form of the disease. DCM is a
progressive disease that is characterized by ventricular
dilatation and systolic dysfunction. In patients with LMNA
mutations, DCM is usually accompanied by conduction
defects and may include skeletal muscle involvement.
Missense mutations and splicing defects in LMNA have
also been linked to autosomal dominant limb girdle
muscular dystrophy type 1B (LGMD1B) (Muchir et al.
2000). LGMD1B is a slowly progressing disease character-
ized by weakness and wasting of shoulder and pelvic
muscles due to necrosis, and is accompanied by cardiac
conduction defects in some patients.
Mutations in LMNA have been linked to Dunnigan-type
familial partial lipodystrophy (FPLD) by several groups
(Cao and Hegele 2000; Shackleton et al. 2000; Speckman et
al. 2000). FPLD is an autosomal dominant disorder
characterized by loss of fat tissue from the extremities and
excess fat accumulation on the face and neck, beginning at
puberty, and is accompanied by insulin-resistant diabetes,
hyperlipidemia and atherosclerotic vascular disease. Ap-
proximately 90% of the mutations in FPLD are located in
exon 8, with substitutions at arginine at 482 amino acid
position being found in 75% of cases; mutation of this
residue has been shown to block binding of the adipocyte
differentiation factor SREBP1 (Lloyd et al. 2002).
An autosomal recessive mutation at R298C of LMNA
gives rise to Charcot-Marie-Tooth disorder (CMT) type
2B, which is an axonal neuropathy characterized by
peripheral loss of large myelinated fibres and axonal
degeneration that results in sensory impairment with some
reduction in motor nerve conduction velocity (De Sandre-
Giovannoli et al. 2002).
The most deleterious effects of mutations in LMNA have
been observed in the premature ageing disorder Hutchinson-
Gilford progeria syndrome (HGPS) (De Sandre-Giovannoli
et al. 2003; Eriksson et al. 2003). HGPS is an autosomal
dominant condition that is characterized by short stature,
early thinning of skin, loss of subcutaneous fat, premature
atherosclerosis and cardiac failure leading to death. HGPS is
a very rare disorder that affects about one in a million and
leads to early mortality, usually in the second decade of life.
The majority of cases are due to a de novo missense
mutation (GGC to GGT) in exon 11 that does not cause an
amino acid change (G608G) but leads to creation of an
abnormal splice donor site which results in expression of a
truncated pre-lamin A protein (also termed progerin or
lamin AΔ50) with loss of 50 amino acids from the C-
terminus including the second ZMPSTE24 cleavage site,
resulting in a permanently farnesylated C-terminus. Man-
dibuloacral dysplasia (MAD) is a rare, autosomal recessive
disorder characterized by postnatal growth retardation, skull
and facial anomalies, skeletal abnormalities, mottled skin
pigmentation, partial or generalized lipodystrophy and signs
of premature ageing. Most patients with MAD type A, who
exhibit partial lipodystrophy, have a R527H homozygous
mutation in LMNA (Novelli et al. 2002). On the other hand,
MAD type B, characterized by generalized loss of fat
involving face, trunk and extremities, is caused by muta-
tions in ZMPSTE24 protease, which is involved in the
processing of pre-lamin A to lamin A (Agarwal et al. 2003).
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Mutations in LMNA as well as ZMPSTE24 are associated
with restrictive dermopathy, which is a rare disorder
characterized by intra-uterine growth retardation, tight and
rigid skin with erosions, facial malformation, bone miner-
alization defects and early neonatal mortality (Navarro et al.
2004, 2005; Shackleton et al. 2005).
A few disease-causing mutations have been identified in
the B-type lamin genes. Missense mutations in the lamin B2
gene have been associated with acquired partial lipodys-
trophy, which is a rare disease that results in a gradual loss
of subcutaneous fat from the head, neck, upper extremities
and thorax but not from the lower extremities (Hegele et al.
2006). Duplications of the lamin B1 gene have been
identified in patients with adult onset leukodystrophy, a
progressive neurological disorder characterized by loss of
myelin in the central nervous system (Padiath et al. 2006).
In general, mutations in the B-type lamins are likely to be
highly deleterious, based on findings in mouse models. The
knock-out of the mouse lamin B1 gene causes defects in
embryonic development (Vergnes et al. 2004) and lamin
B2-null mice show severe brain abnormalities (Coffinier et
al. 2010). Genetic diseases due to mutations in genes
encoding proteins that associate with lamins have also been
reported (Worman and Courvalin 2005; Dechat et al. 2008;
Parnaik 2008).
3. Deleterious effects of lamin mutations on nuclear
organization and functions
Lamins play a crucial role in maintenance of nuclear shape
and integrity, organization of chromatin and distribution of
nuclear pore complexes. Lamins are also involved in the
spatial organization of DNA replication, transcription and
mitotic events, and are specifically cleaved during apopto-
sis. Binding of lamins to specific gene regulatory factors
influences cellular signalling pathways involved in muscle
differentiation, adipocyte differentiation, DNA repair, cellu-
lar proliferation and transforming growth-factor-β-mediated
signalling (Broers et al. 2006; Capell and Collins 2006;
Melcer et al. 2007; Dechat et al. 2008; Parnaik 2008). The
functional role of lamins is strongly supported by data with
disease-causing lamin mutants as well as earlier findings
with loss-of-function lamin mutants in C. elegans and D.
melanogaster, and dominant-negative mutants in cultured
cells. Recent studies suggest that the lamina might play an
active role in genome organization through specific binding
to large genomic segments (Kind and van Steensel 2010).
HGPS cells exhibit severe nuclear abnormalities such as
lobulation, blebbing and loss of heterochromatin (Eriksson et
al. 2003; De Sandre-Giovannoli et al. 2003; Goldman et al.
2004; Taimen et al. 2009). The accumulation of farnesylated
pre-lamin A in HGPS cells has been proposed to cause
aberrant nuclear morphology and pathogenesis (Fong et al.
2004). This is supported by evidence for improvement of
nuclear morphology by blocking farnesyl transferase activity
in HGPS cells (Capell et al. 2005; Columbaro et al. 2005;
Yang et al. 2005) or knocking out the Zmpste24 gene in a
mouse model (Fong et al. 2006). Importantly, administration
of a farnesyl transferase inhibitor to Zmpste24-deficient mice
can decrease progeria-like disease symptoms and improve
survival (Fong et al. 2006), raising the possibility of
beneficial effects of these drugs in humans. However, a
caveat to the long-term use of farnesyl transferase inhibitors
is a recent report that non-farnesylated pre-lamin A causes
cardiomyopathy in mice (Davies et al. 2010).
Cells from patients with other laminopathies also display
abnormal nuclear morphology. Fibroblasts from patients
with EMD, LGMD, DCM and FPLD due to LMNA
mutations show abnormal nuclear phenotypes with nuclear
blebbing and aberrant lamin foci in up to 20% of the cells
(Vigouroux et al. 2001; Capanni et al. 2003; Favreau et al.
2003; Muchir et al. 2004). Exogenous expression of several
lamin A/C disease mutants in mouse or human cells causes
aberrant nuclear morphology, altered lamina assembly,
mislocalization of emerin and disruption of the endogenous
nuclear lamina (Östlund et al. 2001; Raharjo et al. 2001;
Vigouroux et al. 2001; Favreau et al. 2003; Manju et al.
2006). Aberrant nuclear morphology results in cellular
Figure 1. Schematic of lamin A protein structure and disease mutations identified in various laminopathies. Lamin A comprises a rod
domain containing the α-helical segments 1A, 1B, 2A and 2B, which are flanked by a short head domain and a tail domain that harbours
an Ig-fold motif. Mutations leading to EMD, LGMD1B and DCM occur throughout the protein (approximately 200 mutations have been
identified), and a few EMD mutations are indicated (G232E, Q294P, R386K). Most cases of FPLD bear a mutation at R482, whereas
those with MAD harbour the mutation R527H. An R298C mutation leads to CMT2B. Majority of HGPS patients bear a mutation at G608,
which results in abnormal splicing of pre-lamin A and production of a mutant lamin A protein with a deletion of amino acid residues 607–
656 (lamin AΔ50; see text for details).
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senescence, downregulation of transcription, impaired DNA
repair and apoptosis (Capanni et al. 2003; Goldman et al.
2004; Lammerding et al. 2004; Manju et al. 2006; Gurudatta
et al. 2010). An interesting observation is that nuclei from old
individuals acquire defects that are similar to those seen in
cells from HGPS patients, and this has been attributed to
accumulation of progerin (Scaffidi and Misteli 2006).
4. Molecular and cellular basis of pathogenesis
The reported molecular and cellular defects in laminopathic
cells range from susceptibility to physical stress due to
weakening of the nuclear lamina-envelope network to alter-
ations in tissue-specific gene expression patterns and altered
protein–protein interactions. Interestingly, in certain cases,
lamin misexpression can trigger degradation of key regulatory
proteins in the cell, some of which have tissue-specific
functions. These are described in greater detail below.
As the majority of mutations in LMNA affect muscle
tissue, there is considerable interest in understanding the
role played by A-type lamins in muscle development and
the effects of mutations on this process. Valuable insights
into cellular defects associated with lamin A deficiency, in
particular, those leading to muscular dystrophy and cardio-
myopathy, have been obtained from the mouse lamin A
gene knock-out model (Sullivan et al. 1999). Lmna−/− mice
show symptoms of EMD and DCM and die by 6–8 weeks
of age. Fibroblasts from Lmna−/− mice show aberrant
nuclear morphology and herniations of the envelope, and
in response to mechanical strain, these fibroblasts exhibit
increased nuclear deformations and defective mechano-
transduction, together with reduced expression of genes
activated by NF-κB (Lammerding et al. 2004). Cardio-
myocytes from these mice show abnormal nuclear archi-
tecture, relocalization of heterochromatin to the nuclear
interior and changes in localization of the cytoskeletal
filament protein desmin, leading to contractile dysfunction
(Nikolova et al. 2004). Activation of the mitogen-activated
protein kinase (MAPK) signalling pathway has been
observed in the H222P-knock-in mouse model of EMD
(Muchir et al. 2007).
Certain markers of muscle differentiation such as MyoD
and pRb, as well as desmin are decreased in Lmna−/−
myoblasts (Frock et al. 2006). Both MyoD and desmin
transcripts are reduced in proliferating Lmna−/− myoblasts
but pRb transcript levels are normal. The degradation of
pRb protein in Lmna−/− fibroblasts can be reversed by
treatment with proteasomal inhibitors or ectopic expression
of lamin A/C, suggesting that a normal lamina is required
for pRb stability (Johnson et al. 2004). In addition to
dysfunction of pRb in terminal differentiation, the pRb-
mediated G1-S phase transition is hindered in HGPS cells,
Figure 2. Model for effects of lamin misexpression on protein stability and nuclear structure. Expression of laminopathy mutants or
lamin A/C shRNA leads to activation of specific E3 ubiquitin ligases such as RNF123 and HECW2, as well as the F-box protein
FBXW10, resulting in increased proteasomal degradation (P) of HP1α and β (blue) and other regulatory factors (brown), as well as
dispersal of emerin (orange) and aberrant nuclear lamina morphology (maroon).
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probably due to inhibition of phosphorylation of pRb by
Cdk4 kinase (Dechat et al. 2007); these cells also display
abnormal localization of progerin during mitosis and mitotic
defects (Cao et al. 2007; Dechat et al. 2007). C2C12
myoblasts stably expressing a common EMD-causing lamin
A mutation, R453W, are deficient in expression of
myogenic markers like myogenin, do not exit the cell cycle
properly and are eventually targeted for apoptosis (Favreau
et al. 2004). Differentiation is also impaired in myoblasts
expressing the EMD mutants G232E, Q294P or R386K
(Parnaik and Manju 2006).
In fibroblasts from an LGMD1B patient with a homozy-
gous LMNA nonsense mutation (Y259X), which leads to
absence of lamin A, the integral membrane proteins emerin
and nesprin-1α are mislocalized to the ER and subsequently
degraded; this degradation is mediated by the proteasomal
machinery (Muchir et al. 2006). Proteomics analysis has
demonstrated that reduction of lamin A/C to ~10% of
normal values by an shRNA approach in HeLa cells leads to
depletion of 34 proteins, most of which are involved in
cytoskeletal organization, cell cycle regulation and prolifer-
ation (Chen et al. 2009).
Fibroblasts from the Zmpste24-null mouse, which is a
model for progeria, show genomic instability, higher
sensitivity to DNA damaging agents, and impairment in
recruitment of repair proteins such as p53 binding protein 1
(53BP1) and Rad51 to sites of DNA lesions (Liu et al.
2005), as well as upregulation of p53 targets (Varela et al.
2005). In Lmna−/− fibroblasts, 53BP1 is degraded by the
proteasomal machinery, and this may contribute to telomere
dysfunction in these cells (Gonzalez-Suarez et al. 2009). In
cell culture models, lamin mutants impair the formation of
DNA repair foci and hinder the recruitment of 53BP1 to
repair sites after short-term DNA damage; these mutants
cause degradation of ATM-and-Rad3-related (ATR) kinase
in untreated cells (Manju et al. 2006).
Loss of heterochromatin in HGPS cells is accompanied
by downregulation of trimethylation at lysine 9 of histone
H3 (H3K9), which normally marks pericentric constitutive
heterochromatin (Columbaro et al. 2005; Shumaker et al.
2006). Furthermore, the inactive X chromosome from a
female HGPS patient shows loss of trimethylation at lysine
27 of histone H3 (H3K27), a mark for facultative
heterochromatin, which results in reduced association with
heterochromatin protein 1α (HP1α) (Shumaker et al. 2006).
Cells from patients with MAD type A due to a R527H
mutation in LMNA also exhibit accumulation of pre-lamin A
and loss of peripheral heterochromatin, together with
mislocalization of HP1β, trimethylated H3K9 and LBR
(Filesi et al. 2005). A recent study has reported another
progeria mutation, E145K that is highly disruptive of
nuclear structure but does not respond to treatment with a
farnesyl transferase inhibitor (Taimen et al. 2009).
Expression of the lamin A EMD mutants G232E,
Q294P and R386K in HeLa cells results in depletion of
HP1α and β isoforms; treatment with proteasomal
inhibitors leads to restoration of levels of HP1 isoforms,
stable association of lamin mutants with the nuclear
periphery, rim localization of the inner nuclear membrane
lamin-binding protein emerin and partial improvement of
nuclear morphology. FBXW10, a member of the F-box
family of substrate-binding proteins that are components
of RING ubiquitin ligases such as SCF-ligase, is induced
several-fold in cells expressing lamin mutants, and
expression of FBXW10 directly leads to depletion of
HP1α and β and dispersal of emerin (Chaturvedi and Parnaik
2010). This is the first report on the identification of specific
components of the ubiquitination pathway that are activated
by lamin misexpression (see schematic in figure 2). Two
other ubiquitin ligases that are upregulated upon expres-
sion of lamin mutants or in lamin A knock-down cells,
RNF123 and HECW2, are also involved in degradation of
HP1 isoforms and other regulatory proteins (Parnaik,
Chaturvedi and Muralikrishna, unpublished work). Thus
ubiquitin-mediated proteasomal degradation of essential
nuclear proteins may afford a distinct mechanism for the
deleterious effects of disease-causing lamin mutants.
5. Concluding remarks
Lamins are essential for nuclear integrity and spatial
organization of nuclear functions, and they also provide
interconnections between the cytoplasm and the nucleus.
Binding interactions between lamins and specific proteins
lead to the formation of critical regulatory networks. Studies
with laminopathic mutations in both cellular and animal
models have given valuable information on the role of
lamins in key signalling pathways. It is becoming increas-
ingly evident that certain highly deleterious mutations in
lamin A/C are able to affect multiple cellular processes,
leading to general cellular toxicity and cell death. Both
decreased levels of lamin A/C and lamin missense muta-
tions trigger proteasomal degradation of essential proteins.
Recent findings on the identification of specific components
of the ubiquitination pathway that are activated by lamin
misexpression have provided new insights into these
processes. Further studies should yield a better understand-
ing of the mechanism of activation of ubiquitin ligases in
laminopathic cells.
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